The winners of BOB phase 1 and phase 2 are announced here. Learn more about the winners of past BOB events here.

Phase 1 - The three most innovative business ideas!

39 teams from 10 countries and 3 continents contested in phase 1 of the competition - a strong signal for the innovative and entrepreneurial power in the life sciences! 44% of the projects belonged to Medical Technology, 38% to Red Biotechnology and 15% to Supply and Services.

37 BOB evaluators from 7 countries performed a total of 234 evaluations providing detailed feedback to the participants.

On April 29th 2010, the three winning teams were presented to the public and awarded a cash prize of € 1,500 each at a ceremony held in the premises of Austria Wirtschaftsservice. Find below a short presentation of the winning teams in alphabetical order.

AMBERwest

Dr. Andreas KUBIN, Dr. Martina ZEDERBAUER

Development of selective inhibitors for human peroxidases for treatment of chronic inflammatory and neurodegenerative diseases.

Profem

Dr. Marion NOE

Development of a new combination therapy for the treatment of dermal and mucosal candidiasis, with special respect to vulvovaginitis caused by Candida spp., thereby introducing a therapeutic concept which takes host defense mechanisms into account. This project is complemented by an idea to develop compounds for the treatment of urge incontinence (UUI) and overactive bladder syndrome (OAB).

Sorbus

Dr. Frank SAMS-DODD

Discovery and development of novel treatments for complicated wounds, cancer and CNS disorders. The first product SertaSil has been shown to accelerate wound healing substantially and to treat wound infections in patients with acute and chronic wounds and burns.